Corcept Therapeutics Announces First Quarter 2016 Financial Results and Provides Corporate Update by longitudeadmin | May 3, 2016 | Portfolio News
Collegium Receives FDA Approval for Xtampza™ ER, an Analgesic with Abuse-Deterrent Properties for the Treatment of Chronic Pain by longitudeadmin | Apr 26, 2016 | Portfolio News
Zavante Initiates The ZEUS Study For ZTI-01 For The Treatment Of Complicated Urinary Tract Infections by longitudeadmin | Apr 14, 2016 | Portfolio News
Kala Pharmaceuticals Announces Closing of $68 Million Series C Financing by longitudeadmin | Apr 13, 2016 | Portfolio News
Zavante Therapeutics Closes $45 Million Series A Financing In Support Of U.S. Development For A First-In-Class Injectable Antibiotic by longitudeadmin | Mar 30, 2016 | Portfolio News
